Novonesis Earnings: Strong Food and Beverages Growth Cushions US Dietary Supplements Slump
Novonesis reported third-quarter organic sales growth of 6% and adjusted EBITDA margin of 38.3%, in line with company-compiled consensus on sales and slightly ahead on margin. Management confirmed 2026 guidance. Shares were up around 5% in intraday trading on Nov. 5.